indication for semaglutide Two-year effects of in adults with overweight or obesity: the STEP 5 trial How Many People Can Raise

How Semaglutide Addresses PCOS Metabolic Dysfunction Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone regulating blood sugar and appetite

doi: 10.1007/s00125-017-4450-9 3 HolstJJGasbjergLSRosenkildeMM

Food and Drug Administration (FDA) in 2022

However, individual results vary based on factors like starting weight, diet adherence, physical activity level, and how your body responds to the medication

The joint associations of maternal bmi and glycemia with childhood adiposity

Pregnancy and breastfeeding: Clinical trial safety data in pregnant or breastfeeding women are limited